CD4 and neoplasm: Interaction of CD154 with CD40 has been demonstrated to mediate anti-tumoral immune responses by enhancing the immunogenic cell death of tumor cells, activation of antigen presenting cells, production of proinflammatory factors, co-stimulation of CD4+ and CD8+ T cells, and the tumor cell susceptibility to T cell lysis (64, 65).